Publications

1. Xuan W, Wang S, Alarcon-Calderon A, Bagwell MS, Para R, Wang F, Zhang C, Tian X, Stalboerger P, Peterson T, Sabbah MS, Du Z, Sarrafian T, Mahlberg R, Hillestad ML, Rizzo SA, Paradise CR, Behfar A, Vassallo R. Nebulized platelet-derived extracellular vesicles attenuate chronic cigarette smoke-induced murine emphysema. Transl Res. 2024 Jul; 269:76-93 Epub 2024 Feb 06
   View PubMed
2. Inglis SS, Asleh R, Iyer VN, Schettle SD, Spencer PJ, Villavicencio MA, Rodeheffer RJ, Kushwaha SS, Behfar A, Rosenbaum AN. Inhibition of angiogenesis in the management of refractory gastrointestinal bleeding in patients with LVAD support. Artif Organs. 2024 Jun; 48 (6):646-654 Epub 2023 Dec 22
   View PubMed
3. Pumford AD, Staricha KL, Kunkel ET, Armstrong MF, Behfar A, Van Abel KM. Exosome Therapy for a Nonhealing Scalp Wound Following Chemoradiation and Surgical Therapy. Mayo Clin Proc. 2024 Jun; 99 (6):1006-1012
   View PubMed
4. Livia C, Inglis S, Crespo-Diaz R, Rizzo S, Mahlberg R, Bagwell M, Hillestad M, Yamada S, Meenakshi Siddharthan DV, Singh RD, Li X, Arrell DK, Stalboerger P, Witt T, El Sabbagh A, Rihal M, Rihal C, Terzic A, Bartunek J, Behfar A. Infliximab Limits Injury in Myocardial Infarction. J Am Heart Assoc. 2024 May 7; 13 (9):e032172 Epub 2024 May 03
   View PubMed
5. Inglis SS, Rosenbaum AN, Rizzo SA, Anderson JH, Yalamuri S, Spencer PJ, Villavicencio MA, Behfar A. Novel Left Ventricular Unloading Strategies in Patients on Peripheral Venoarterial Extracorporeal Membrane Oxygenation Support. ASAIO J. 2024 May 1; 70 (5):396-403 Epub 2024 Jan 02
   View PubMed
6. Garmany A, Inglis SS, Behfar A, Rosenbaum AN. Biventricular catheterization combined with pressure-volume loop monitoring provides insight into the dynamic effects of left ventricular assist devices ramp on right ventricular function. Catheter Cardiovasc Interv. 2024 Apr; 103 (5):799-802 Epub 2024 Mar 10
   View PubMed
7. Rizzo SA, Bagwell MS, Schiebel P, Rolland TJ, Mahlberg RC, Witt TA, Nagel ME, Stalboerger PG, Behfar A. Pulmonary Biodistribution of Platelet-Derived Regenerative Exosomes in a Porcine Model. Int J Mol Sci. 2024 Feb 24; 25 (5)
   View PubMed
8. Yamada S, Bartunek J, Povsic TJ, Cotter G, Davison BA, Edwards C, Behfar A, Metra M, Filippatos GS, Vanderheyden M, Wijns W, Terzic A. Cell Therapy Improves Quality-of-Life in Heart Failure: Outcomes From a Phase III Clinical Trial. Stem Cells Transl Med. 2024 Feb 14; 13 (2):116-124
   View PubMed
9. Wyles S, Eaton Jankov L, Copeland K, Bucky LP, Paradise C, Behfar A. A Comparative Study of Two Topical Treatments for Photoaging of the Hands. Plast Reconstr Surg. 2023 Dec 12 [Epub ahead of print]
   View PubMed
10. Wang Y, Shi G, Huang TCT, Li J, Long Z, Reisdorf R, Shin AY, Amadio P, Behfar A, Zhao C, Moran SL. Enhancing Functional Recovery after Segmental Nerve Defect Using Nerve Allograft Treated with Plasma-Derived Exosome. Plast Reconstr Surg. 2023 Dec 01; 152(6):1247-1258. Epub 2023 Mar 14.
    View PubMed
11. Beetler DJ, Bruno KA, Watkins MM, Xu V, Chekuri I, Giresi P, Di Florio DN, Whelan ER, Edenfield BH, Walker SA, Morales-Lara AC, Hill AR, Jain A, Auda ME, Macomb LP, Shapiro KA, Keegan KC, Wolfram J, Behfar A, Stalboerger PG, Terzic A, Farres H, Cooper LT, Fairweather D. Reconstituted Extracellular Vesicles from Human Platelets Decrease Viral Myocarditis in Mice. Small. 2023 Dec; 19 (49):e2303317 Epub 2023 Aug 23
    View PubMed
12. Kaufman-Janette J, Cazzaniga A, Jacobson A, Eaton Jankov LL, Copeland K, Behfar A, Wyles S. Effect of Topical Platelet Extract Daily Serum as a Cosmetic Product to Reduce Facial Redness. J Clin Aesthet Dermatol. 2023 Oct; 16 (10):48-51
    View PubMed
13. Mazzucchelli L, Sarcon AK, Huang TCT, Li J, Berry CE, Houdek MT, Behfar A, Zhao C, Moran SL. A Ready-to-Use Purified Exosome Product for Volumetric Muscle Loss and Functional Recovery. Tissue Eng Part A. 2023 Sep; 29(17-18):481-490.
    View PubMed
14. Dayan S, Gandhi N, Wilson J, Kola E, Jankov LE, Copeland K, Paradise C, Behfar A. Safety and efficacy of human platelet extract in skin recovery after fractional CO(2) laser resurfacing of the face: A randomized, controlled, evaluator-blinded pilot study. J Cosmet Dermatol. 2023 Sep; 22 (9):2464-2470 Epub 2023 July 07
    View PubMed
15. Singh M, El Sabbagh A, Lewis BR, Kanwar A, Terzic CM, Al-Hijji MA, Behfar A, Kirkland JL. Clinical Significance of Biological Age in Patients Undergoing Percutaneous Coronary Intervention. Mayo Clin Proc. 2023 Aug; 98(8):1137-1152.
    View PubMed
16. Inglis SS, Villavicencio MT, Spencer PJ, Schettle SD, Stulak JM, Clavell AL, Kushwaha SS, Behfar A, Rosenbaum AN. Interventricular-Septal Output While Supported on Left Ventricular Assist Device Therapy. ASAIO J. 2023 May 1; 69 (5):424-428 Epub 2022 Nov 07
    View PubMed
17. Rizzo SA, Yalamuri SM, Rosenbaum AN, Anavekar NS, Miranda WR, Daly R, Dearani JA, Villavicencio M, Behfar A. Percutaneous Mechanical Circulatory Support as a Bridge to Transplantation in Ebstein Anomaly. Mayo Clin Proc. 2023 Apr; 98 (4):626-630
    View PubMed
18. Meenakshi-Siddharthan DV, Livia C, Peterson TE, Stalboerger P, Attia ZI, Clavell AL, Friedman PA, Kapa S, Noseworthy PA, Schafer MJ, Stulak JM, Behfar A, Boilson BA. Artificial Intelligence-Derived Electrocardiogram Assessment of Cardiac Age and Molecular Markers of Senescence in Heart Failure. Mayo Clin Proc. 2023 Mar; 98 (3):372-385
    View PubMed
19. Hull JV, Padkins MR, El Hajj S, Al-Hijji MA, Kanwar A, Crusan DJ, Gulati R, El Sabbagh A, Park JY, Lennon RJ, Behfar A, Rihal CS, Singh M. Risks of Right Heart Catheterization and Right Ventricular Biopsy: A 12-year, Single-Center Experience. Mayo Clin Proc. 2023 Mar; 98 (3):419-431
    View PubMed
20. Adedinsewo D, Hardway HD, Morales-Lara AC, Wieczorek MA, Johnson PW, Douglass EJ, Dangott BJ, Nakhleh RE, Narula T, Patel PC, Goswami RM, Lyle MA, Heckman AJ, Leoni-Moreno JC, Steidley DE, Arsanjani R, Hardaway B, Abbas M, Behfar A, Attia ZI, Lopez-Jimenez F, Noseworthy PA, Friedman P, Carter RE, Yamani M. Non-invasive detection of cardiac allograft rejection among heart transplant recipients using an electrocardiogram based deep learning model. Eur Heart J Digit Health. 2023 Mar; 4 (2):71-80 Epub 2023 Jan 13
    View PubMed
21. Vyas KS, Kaufman J, Munavalli GS, Robertson K, Behfar A, Wyles SP. Exosomes: the latest in regenerative aesthetics. Regen Med. 2023 Feb; 18 (2):181-194 Epub 2023 Jan 04
    View PubMed
22. Shi G, Long Z, De la Vega RE, Behfar A, Moran SL, Evans C, Zhao C. Purified exosome product enhances chondrocyte survival and regeneration by modulating inflammation and promoting chondrogenesis. Regen Med. 2023 Jan; 18 (1):55-71 Epub 2022 Oct 18
    View PubMed
23. Shadrin IY, Holmes DR, Behfar A. Left Internal Mammary Artery as an Endocrine Organ: Insights Into Graft Biology and Long-term Impact Following Coronary Artery Bypass Grafting. Mayo Clin Proc. 2023 Jan; 98 (1):150-162
    View PubMed
24. Miller CM, L Enninga EA, Rizzo SA, Phillipps J, Guerrero-Cazares H, Destephano CC, Peterson TE, Stalboerger PG, Behfar A, Khan Z. Platelet-derived exosomes induce cell proliferation and wound healing in human endometrial cells. Regen Med. 2022 Nov; 17 (11):805-817 Epub 2022 Oct 04
    View PubMed
25. Rolland TJ, Peterson TE, Singh RD, Rizzo SA, Boroumand S, Shi A, Witt TA, Nagel M, Kisby CK, Park S, Rowe LA, Paradise CR, Becher LRE, Paradise BD, Stalboerger PG, Trabuco EC, Behfar A. Author Correction: Exosome biopotentiated hydrogel restores damaged skeletal muscle in a porcine model of stress urinary incontinence. NPJ Regen Med. 2022 Oct 31; 7 (1):65
    View PubMed
26. Rolland TJ, Peterson TE, Singh RD, Takhter R, Rizzo SA, Boroumand S, Shi A, Witt TA, Nagel M, Kisby CK, Park S, Rowe LA, Paradise CR, Becher LRE, Paradise BD, Stalboerger PG, Trabuco EC, Behfar A. Exosome biopotentiated hydrogel restores damaged skeletal muscle in a porcine model of stress urinary incontinence. NPJ Regen Med. 2022 Sep 29; 7 (1):58 Epub 2022 Sept 29
    View PubMed
27. Proffer SL, Paradise CR, DeGrazia E, Halaas Y, Durairaj KK, Somenek M, Sivly A, Boon AJ, Behfar A, Wyles SP. Efficacy and Tolerability of Topical Platelet Exosomes for Skin Rejuvenation: Six-Week Results. Aesthet Surg J. 2022 Sep 14; 42(10):1185-1193.
    View PubMed
28. Rosenbaum AN, Geske JB, Stulak JM, Kushwaha SS, Clavell AL, Behfar A. Left Ventricular Hemodynamics and Relationship With Myocardial Recovery and Optimization in Patients Supported on CF-LVAD Therapy. J Card Fail. 2022 May; 28 (5):799-806 Epub 2021 Dec 17
    View PubMed
29. Rhodes NG, Johnson TF, Boyum JH, Khandelwal A, Howell BD, Froemming AT, Behfar A. Radiology of Intra-Aortic Balloon Pump Catheters. Radiol Cardiothorac Imaging. 2022 Apr; 4 (2):e210120 Epub 2022 Apr 14
    View PubMed
30. Wan R, Hussain A, Behfar A, Moran SL, Zhao C. The Therapeutic Potential of Exosomes in Soft Tissue Repair and Regeneration. Int J Mol Sci. 2022 Mar 31; 23 (7)
    View PubMed
31. Rosenbaum AN, Ternus BW, Stulak JM, Clavell AL, Schettle SD, Behfar A, Jentzer JC. Optimal Hemodynamics and Risk of Severe Outcomes Post-Left Ventricular Assist Device Implantation. ASAIO J. 2022 Mar 01; 68(3):325-332.
    View PubMed
32. Rosenbaum AN, Antaki JF, Behfar A, Villavicencio MA, Stulak J, Kushwaha SS. Physiology of Continuous-Flow Left Ventricular Assist Device Therapy. Compr Physiol. 2021 Dec 29; 12 (1):2731-2767
    View PubMed
33. Wellings EP, Huang TC, Li J, Peterson TE, Hooke AW, Rosenbaum A, Zhao CD, Behfar A, Moran SL, Houdek MT. Intrinsic Tendon Regeneration After Application of Purified Exosome Product: An In Vivo Study. Orthop J Sports Med. 2021 Dec; 9(12):23259671211062929. Epub 2021 Dec 17.
    View PubMed
34. Smith C, Crowley A, Munsie M, Behfar A, DeMartino ES, Staff NP, Shapiro SA, Master Z. Academic Physician Specialists' Approaches to Counseling Patients Interested in Unproven Stem Cell and Regenerative Therapies-A Qualitative Analysis. Mayo Clin Proc. 2021 Dec; 96 (12):3086-3096 Epub 2021 Aug 26
    View PubMed
35. Houdek MT, Wyles CC, Smith JH, Terzic A, Behfar A, Sierra RJ. Hip decompression combined with bone marrow concentrate and platelet-rich plasma for corticosteroid-induced osteonecrosis of the femoral head : mid-term update from a prospective study. Bone Jt Open. 2021 Nov; 2 (11):926-931
    View PubMed
36. Yamada S, Bartunek J, Behfar A, Terzic A. Mass Customized Outlook for Regenerative Heart Failure Care. Int J Mol Sci. 2021 Oct 22; 22 (21)
    View PubMed
37. Kisby CK, Shadrin IY, Rolland TJ, Stalboerger PG, Zhou B, Trabuco EC, Behfar A, Occhino JA. Exosome-Induced Vaginal Tissue Regeneration in a Porcine Mesh Exposure Model. Female Pelvic Med Reconstr Surg. 2021 Oct 1; 27 (10):609-615
    View PubMed
38. Ren Y, Zhang S, Wang Y, Jacobson DS, Reisdorf RL, Kuroiwa T, Behfar A, Moran SL, Steinmann SP, Zhao C. Effects of purified exosome product on rotator cuff tendon-bone healing in vitro and in vivo. Biomaterials. 2021 Sep; 276:121019 Epub 2021 July 23
    View PubMed
39. Arrell DK, Crespo-Diaz RJ, Yamada S, Jeon R, Garmany A, Park S, Adolf JP, Livia C, Hillestad ML, Bartunek J, Behfar A, Terzic A. Secretome signature of cardiopoietic cells echoed in rescued infarcted heart proteome. Stem Cells Transl Med. 2021 Sep; 10 (9):1320-1328 Epub 2021 May 28
    View PubMed
40. Kassi M, Rosenbaum AN, El Sabbagh A, Boilson B, Behfar A. Hemodynamic Assessment of Dual Obstructive Left Ventricular Assist Device Lesions. Cureus. 2021 Aug; 13 (8):e17180 Epub 2021 Aug 14
    View PubMed
41. Kumar V, Manduca A, Rao C, Ryu AJ, Gibbons RJ, Gersh BJ, Chandrasekaran K, Asirvatham SJ, Araoz PA, Oh JK, Egbe AC, Behfar A, Borlaug BA, Anavekar NS. An under-recognized phenomenon: Myocardial volume change during the cardiac cycle. Echocardiography. 2021 Aug; 38 (8):1235-1244 Epub 2021 June 04
    View PubMed
42. Ikumi A, Gingery A, Toyoshima Y, Zhao C, Moran SL, Livia C, Rolland T, Peterson T, Sabbah MS, Boroumand S, Saffari TM, Behfar A, Shin AY, Amadio PC. Administration of Purified Exosome Product in a Rat Sciatic Serve Reverse Autograft Model. Plast Reconstr Surg. 2021 Aug 1; 148 (2):200e-211e
    View PubMed
43. Rosenbaum AN, Clavell AL, Stulak JM, Behfar A. Accuracy of Noninvasive Blood Pressure Versus Central Aortic Pressure in Patients Supported on Left Ventricular Assist Device Therapy. ASAIO J. 2021 Aug 01; 67(8):e134-e136.
    View PubMed
44. Shi G, Wang Y, Wang Z, Thoreson AR, Jacobson DS, Amadio PC, Behfar A, Moran SL, Zhao C. A novel engineered purified exosome product patch for tendon healing: An explant in an ex vivo model. J Orthop Res. 2021 Aug; 39 (8):1825-1837 Epub 2020 Oct 14
    View PubMed
45. Espinosa S, El Sabbagh A, Behfar A, Patel P. Transcatheter Mitral Valve Repair Using MitraClip in Secondary Mitral Valve Regurgitation Guided by Real-Time Pressure-Volume Loops. Heart Views. 2021 Jul-Sep; 22 (3):212-213 Epub 2021 Oct 11
    View PubMed
46. Yamada S, Jeon R, Garmany A, Behfar A, Terzic A. Screening for regenerative therapy responders in heart failure. Biomark Med. 2021 Jun; 15 (10):775-783 Epub 2021 June 25
    View PubMed
47. Rosenbaum AN, Ternus BW, Pahwa S, Stulak JM, Clavell AL, Schettle SD, Behfar A, Jentzer JC. Risk of Liver Dysfunction After Left Ventricular Assist Device Implantation. Ann Thorac Surg. 2021 Jun; 111 (6):1961-1967 Epub 2020 Oct 12
    View PubMed
48. Ternus B, Behfar A, Schirger J, Barsness G, Eleid M, Patel P, Stulak J, Jentzer J. Outcomes of Ambulatory Heart Failure Patients Managed With an Intra-aortic Balloon Pump Before Left Ventricular Assist Device Implantation. ASAIO J. 2021 Apr 1; 67 (4):430-435
    View PubMed
49. Rosenbaum AN, Jain CC, Shadrin IY, El Hajj SC, El Sabbagh A, Behfar A. Percutaneous Axillary Intra-aortic Balloon Pump Insertion Technique as Bridge to Advanced Heart Failure Therapy. ASAIO J. 2021 Apr 01; 67(4):e81-e85.
    View PubMed
50. Sabbah MS, Rosenbaum AN, Behfar A. Listening for Thrombosis. Mayo Clin Proc 2021 Apr; 96 (4):841-843
    View PubMed
51. Daly RC, Rosenbaum AN, Dearani JA, Clavell AL, Pereira NL, Boilson BA, Frantz RP, Behfar A, Dunlay SM, Rodeheffer RJ, Schirger JA, Taner T, Gandhi MJ, Heimbach JK, Rosen CB, Edwards BS, Kushwaha SS. Heart-After-Liver Transplantation Attenuates Rejection of Cardiac Allografts in Sensitized Patients. J Am Coll Cardiol. 2021 Mar 16; 77 (10):1331-1340
    View PubMed
52. Hargraves IG, Behfar A, Simha V, Donoghue C, Renner AS, Montori VM, Brito JP. From tissue to human regeneration: the development of a comprehensive regenerative care clinic for people with diabetes. Regen Med. 2021 Mar; 16 (3):219-228 Epub 2021 Mar 16
    View PubMed
53. Kisby CK, Shadrin IY, Peng LT, Stalboerger PG, Trabuco EC, Behfar A, Occhino JA. Impact of Repeat Dosing and Mesh Exposure Chronicity on Exosome-Induced Vaginal Tissue Regeneration in a Porcine Mesh Exposure Model. Female Pelvic Med Reconstr Surg. 2021 Mar 1; 27 (3):195-201
    View PubMed
54. Yamada S, Behfar A, Terzic A. Regenerative medicine clinical readiness. Regen Med. 2021 Mar; 16 (3):309-322 Epub 2021 Feb 24
    View PubMed
55. Li M, Yamada S, Shi A, Singh RD, Rolland TJ, Jeon R, Lopez N, Shelerud L, Terzic A, Behfar A. Brachyury engineers cardiac repair competent stem cells. Stem Cells Transl Med. 2021 Mar; 10 (3):385-397 Epub 2020 Oct 24
    View PubMed
56. Rosenbaum AN, Stulak JM, Clavell AL, Behfar A. Inadequate left ventricular unloading during ramp is associated with hospitalization or death during left ventricular assist device support. Artif Organs. 2021 Feb; 45(2):115-123. Epub 2020 Sep 03.
    View PubMed
57. Rosenbaum AN, Clavell AL, Stulak JM, Behfar A. Correction of High Afterload Improves Low Cardiac Output in Patients Supported on Left Ventricular Assist Device Therapy. ASAIO J. 2021 Jan 1; 67 (1):32-38
    View PubMed
58. Houdek MT, Wyles CC, Smith JRH, Terzic A, Behfar A, Sierra RJ. Hip decompression combined with bone marrow concentrate and plateletrich plasma for corticosteroid-induced osteonecrosis of the femoral head. Bone and Joint Open. 2021; 2 (11):926-31
    
59. Shi A, Li J, Qiu X, Sabbah M, Boroumand S, Huang TC, Zhao C, Terzic A, Behfar A, Moran SL. TGF-ß loaded exosome enhances ischemic wound healing in vitro and in vivo. Theranostics. 2021; 11(13):6616-6631. Epub 2021 Apr 30.
    View PubMed
60. Kumar V, Ryu AJ, Manduca A, Rao C, Gibbons RJ, Gersh BJ, Chandrasekaran K, Asirvatham SJ, Araoz PA, Oh JK, Egbe AC, Behfar A, Borlaug BA, Anavekar NS. Cardiac MRI demonstrates compressibility in healthy myocardium but not in myocardium with reduced ejection fraction. Int J Cardiol. 2021 Jan 1; 322:278-283 Epub 2020 Aug 29
    View PubMed
61. Ryu AJ, Kumar V, Borlaug BA, Manduca A, Rao CK, Gibbons RJ, Asirvatham SJ, Gersh BJ, Chandrasekaran K, Araoz PA, Oh JK, Egbe AC, Behfar A, Anavekar NS. Systolic-to-diastolic myocardial volume ratio as a novel imaging marker of cardiomyopathy. Int J Cardiol. 2021 Jan 1; 322:272-277 Epub 2020 Aug 12
    View PubMed
62. van Zyl M, Pedrotty DM, Karabulut E, Kuzmenko V, Samfors S, Livia C, Vaidya V, Sugrue A, McLeod CJ, Behfar A, Asirvatham SJ, Gatenholm P, Kapa S. Injectable conductive hydrogel restores conduction through ablated myocardium. J Cardiovasc Electrophysiol. 2020 Dec; 31 (12):3293-3301 Epub 2020 Oct 05
    View PubMed
63. Bartunek J, Terzic A, Davison BA, Behfar A, Sanz-Ruiz R, Wojakowski W, Sherman W, Heyndrickx GR, Metra M, Filippatos GS, Waldman SA, Teerlink JR, Henry TD, Gersh BJ, Hajjar R, Tendera M, Senger S, Cotter G, Povsic TJ, Wijns W, CHART Program. Cardiopoietic stem cell therapy in ischaemic heart failure: long-term clinical outcomes. ESC Heart Fail. 2020 Dec; 7 (6):3345-3354 Epub 2020 Oct 23
    View PubMed
64. Bansal A, Pandey MK, Yamada S, Goyal R, Schmit NR, Jeon R, Nesbitt JJ, Witt TA, Singh RD, Gunderson TM, Boroumand S, Li M, Crespo-Diaz RJ, Hillestad ML, Terzic A, Behfar A, DeGrado TR. [(89)Zr]Zr-DBN labeled cardiopoietic stem cells proficient for heart failure. Nucl Med Biol. 2020 Nov - Dec; 90-91:23-30 Epub 2020 Sept 09
    View PubMed
65. Qi J, Liu Q, Reisdorf RL, Boroumand S, Behfar A, Moran SL, Amadio PC, Gingery A, Zhao C. Characterization of a purified exosome product and its effects on canine flexor tenocyte biology. J Orthop Res. 2020 Aug; 38 (8):1845-1855 Epub 2020 Jan 24
    View PubMed
66. Asleh R, Albitar HAH, Schettle SD, Kushwaha SS, Pereira NL, Behfar A, Stulak JM, Rodeheffer RJ, Iyer VN. Intravenous bevacizumab as a novel treatment for refractory left ventricular assist device-related gastrointestinal bleeding. J Heart Lung Transplant 2020 May; 39 (5):492-495 Epub 2020 Feb 24
    View PubMed
67. Rosenbaum AN, Soldatova A, Stulak JM, Clavell A, Behfar A. Intrinsic Myocardial Function and Relationship with Left Ventricular Unloading in Patients Supported on CF-LVAD Therapy. J Heart Lung Transplant. 2020 Apr; 39 (4S):S158 Epub 2020 Mar 30
    View PubMed
68. Schumer EM, Khullar V, Daly RC, Behfar A, Stulak JM. The Fallout of Heart Allocation System Changes: Practice Patterns and Landscape of the Recipient. J Heart Lung Transplant. 2020 Apr; 39 (4S):S270 Epub 2020 Mar 30
    View PubMed
69. Schumer EM, Khullar V, Daly RC, Behfar A, Stulak JM. The Impact of the New Heart Allocation System: Is Donor-Recipient Mismatch Still Clinically Important? J Heart Lung Transplant. 2020 Apr; 39 (4S):S269 Epub 2020 Mar 30
    View PubMed
70. Pahwa S, Lee G, Tchantchaleishvili V, Weber M, Khullar V, Daly R, Schumer E, Rosenbaum A, Schettle S, Behfar A, Stulak J. Functional Outcomes Not Significantly Impacted by Hemocompatibility-Related Adverse Event Burden among Different Devices. J Heart Lung Transplant. 2020 Apr; 39 (4S):S439-S440 Epub 2020 Mar 30
    View PubMed
71. Rosenbaum AN, Bohman JK, Rehfeldt KH, Stulak JM, Daly RC, Klompas AM, Behfar A, Yalamuri SM. Dual RVAD-ECMO Circuits to Treat Cardiogenic Shock and Hypoxemia Due to Necrotizing Lung Infection: A Case Report. A A Pract. 2020 Apr; 14 (6):e01181
    View PubMed
72. Rosenbaum A, Bohman K, Stulak J, Daly R, Klompas A, Behfar A, Yalamuri S. Dual rvad-ecmo circuits to treat cardiogenic shock and profound hypoxemia due to necrotizing lung infection Journal Of The American College Of Cardiology. 2020 Mar 24; 75(11):2586. Epub 1900 Jan 01.
    
73. Arrell DK, Rosenow CS, Yamada S, Behfar A, Terzic A. Cardiopoietic stem cell therapy restores infarction-altered cardiac proteome. NPJ Regen Med. 2020 Mar 12; 5 (1):5
    View PubMed
74. Arrell DK, Rosenow CS, Yamada S, Behfar A, Terzic A. Cardiopoietic stem cell therapy restores infarction-altered cardiac proteome. NPJ Regen Med. 2020; 5:5 Epub 2020 Mar 12
    View PubMed
75. Gulati R, Behfar A, Narula J, Kanwar A, Lerman A, Cooper L, Singh M. Acute Myocardial Infarction in Young Individuals. Mayo Clin Proc. 2020 Jan; 95 (1):136-156
    View PubMed
76. Yamada S, Arrell DK, Rosenow CS, Bartunek J, Behfar A, Terzic A. Ventricular remodeling in ischemic heart failure stratifies responders to stem cell therapy. Stem Cells Transl Med. 2020 Jan; 9 (1):74-79 Epub 2019 Aug 02
    View PubMed
77. Kazemi NY, Jain C, Bois MC, Behfar A, Olivier K, Markovic SN. Heart Block Caused by Cardiac Metastasis From Merkel Cell Carcinoma: A Case Report. Mayo Clin Proc Innov Qual Outcomes. 2019 Dec; 3 (4):510-516 Epub 2019 Nov 22
    View PubMed
78. Asleh R, Alnsasra H, Daly RC, Schettle SD, Briasoulis A, Taher R, Dunlay SM, Stulak JM, Behfar A, Pereira NL, Frantz RP, Edwards BS, Clavell AL, Kushwaha SS. Predictors and Clinical Outcomes of Vasoplegia in Patients Bridged to Heart Transplantation With Continuous-Flow Left Ventricular Assist Devices. J Am Heart Assoc. 2019 Nov 19; 8 (22):e013108 Epub 2019 Nov 08
    View PubMed
79. AbouEzzeddine OF, Kemp BJ, Borlaug BA, Mullan BP, Behfar A, Pislaru SV, Fudim M, Redfield MM, Chareonthaitawee P. Myocardial Energetics in Heart Failure With Preserved Ejection Fraction. Circ Heart Fail. 2019 Oct; 12 (10):e006240 Epub 2019 Oct 15
    View PubMed
80. Alnsasra H, Asleh R, Schettle SD, Pereira NL, Frantz RP, Edwards BS, Clavell AL, Maltais S, Daly RC, Stulak JM, Rosenbaum AN, Behfar A, Kushwaha SS. Diastolic Pulmonary Gradient as a Predictor of Right Ventricular Failure After Left Ventricular Assist Device Implantation. J Am Heart Assoc. 2019 Aug 20; 8(16):e012073. Epub 2019 Aug 14.
    View PubMed
81. Wyles CC, Paradise CR, Houdek MT, Slager SL, Terzic A, Behfar A, van Wijnen AJ, Sierra RJ. CORR(R) ORS Richard A. Brand Award: Disruption in Peroxisome Proliferator-Activated Receptor-gamma (PPARG) Increases Osteonecrosis Risk Through Genetic Variance and Pharmacologic Modulation. Clin Orthop Relat Res. 2019 Aug; 477 (8):1800-1812
    View PubMed
82. Al-Hijji MA, Lennon RJ, Gulati R, El Sabbagh A, Park JY, Crusan D, Kanwar A, Behfar A, Lerman A, Holmes DR, Bell M, Singh M. Safety and Risk of Major Complications With Diagnostic Cardiac Catheterization. Circ Cardiovasc Interv. 2019 Jul; 12 (7):e007791 Epub 2019 July 09
    View PubMed
83. Yetmar ZA, Lahr B, O'Horo J, Behfar A, Sampathkumar P, Beam E. Pulmonary artery catheter epidemiology of risk in pre-heart-transplant recipients. Infect Control Hosp Epidemiol. 2019 Jun; 40 (6):632-638 Epub 2019 Apr 30
    View PubMed
84. Behfar A, Terzic A. Regeneration for All: An Odyssey in Biotherapy. Eur Heart J. 2019 Apr 1; 40 (13):1033-1035
    View PubMed
85. Rosenbaum AN, Frantz RP, Kushwaha SS, Stulak JM, Maltais S, Behfar A. Novel Left Heart Catheterization Ramp Protocol to Guide Hemodynamic Optimization in Patients Supported With Left Ventricular Assist Device Therapy. J Am Heart Assoc. 2019 Feb 19; 8 (4):e010232
    View PubMed
86. Kassi M, Rosenbaum AN, Wiley BM, Behfar A. Novel Use for Intracardiac Echocardiography: Evaluation of Patients With Continuous Flow Left Ventricular Assist Devices. JACC Cardiovasc Imaging. 2019 Feb; 12 (2):363-366 Epub 2018 Sept 12
    View PubMed
87. Singh RD, Hillestad ML, Livia C, Li M, Alekseev AE, Witt TA, Stalboerger PG, Yamada S, Terzic A, Behfar A. M(3)RNA Drives Targeted Gene Delivery in Acute Myocardial Infarction. Tissue Eng Part A. 2019 Jan; 25 (1-2):145-158 Epub 2018 Sept 21
    View PubMed
88. Livia C, Sugrue A, Witt T, Polkinghorne MD, Maor E, Kapa S, Lehmann HI, DeSimone CV, Behfar A, Asirvatham SJ, McLeod CJ. Elimination of Purkinje Fibers by Electroporation Reduces Ventricular Fibrillation Vulnerability. J Am Heart Assoc. 2018 Aug 7; 7 (15):e009070
    View PubMed
89. Asleh R, Hasin T, Briasoulis A, Schettle SD, Borlaug BA, Behfar A, Pereira NL, Edwards BS, Clavell AL, Joyce LD, Maltais S, Stulak JM, Kushwaha SS. Hemodynamic Assessment of Patients With and Without Heart Failure Symptoms Supported by a Continuous-Flow Left Ventricular Assist Device. Mayo Clin Proc. 2018 Jul; 93 (7):895-903 Epub 2018 June 19
    View PubMed
90. Bartunek J, Terzic A, Behfar A, Wijns W. Clinical Experience With Regenerative Therapy in Heart Failure: Advancing Care With Cardiopoietic Stem Cell Interventions. Circ Res. 2018 May 11; 122 (10):1344-1346
    View PubMed
91. Joyce DL, Redfield MM, Kushwaha SS, Behfar A, Borlaug BA, Daly RC, Sandhu GS, Joyce LD. Pulmonary Pressure Assessment with the Total Artificial Heart. ASAIO J. 2018 May/Jun; 64 (3):e34-e36
    View PubMed
92. Houdek MT, Wyles CC, Collins MS, Howe BM, Terzic A, Behfar A, Sierra RJ. Reply to the Letter to the Editor: Stem Cells Combined With Platelet-rich Plasma Effectively Treat Corticosteroid-induced Osteonecrosis of the Hip: A Prospective Study. Clin Orthop Relat Res 2018 May; 476 (5):1129-1130
    View PubMed
93. Hargraves IG, Behfar A, Foxen JL, Montori VM, Terzic A. Towards regeneration: the evolution of medicine from fighting to building. BMJ. 2018 Apr 17; 361:k1586
    View PubMed
94. Houdek MT, Wyles CC, Collins MS, Howe BM, Terzic A, Behfar A, Sierra RJ. Stem Cells Combined With Platelet-rich Plasma Effectively Treat Corticosteroid-induced Osteonecrosis of the Hip: A Prospective Study. Clin Orthop Relat Res. 2018 Feb; 476 (2):388-397
    View PubMed
95. Chebib FT, Hogan MC, El-Zoghby ZM, Irazabal MV, Senum SR, Heyer CM, Madsen CD, Cornec-Le Gall E, Behfar A, Harris PC, Torres VE. Autosomal Dominant Polycystic Kidney Patients May Be Predisposed to Various Cardiomyopathies. Kidney Int Rep. 2017 Sep; 2 (5):913-923 Epub 2017 June 06
    View PubMed
96. Wang RM, Johnson TD, He J, Rong Z, Wong M, Nigam V, Behfar A, Xu Y, Christman KL. Humanized mouse model for assessing the human immune response to xenogeneic and allogeneic decellularized biomaterials. Biomaterials. 2017 Jun; 129:98-110 Epub 2017 Mar 11
    View PubMed
97. Bartunek J, Terzic A, Davison BA, Filippatos GS, Radovanovic S, Beleslin B, Merkely B, Musialek P, Wojakowski W, Andreka P, Horvath IG, Katz A, Dolatabadi D, El Nakadi B, Arandjelovic A, Edes I, Seferovic PM, Obradovic S, Vanderheyden M, Jagic N, Petrov I, Atar S, Halabi M, Gelev VL, Shochat MK, Kasprzak JD, Sanz-Ruiz R, Heyndrickx GR, Nyolczas N, Legrand V, Guedes A, Heyse A, Moccetti T, Fernandez-Aviles F, Jimenez-Quevedo P, Bayes-Genis A, Hernandez-Garcia JM, Ribichini F, Gruchala M, Waldman SA, Teerlink JR, Gersh BJ, Povsic TJ, Henry TD, Metra M, Hajjar RJ, Tendera M, Behfar A, Alexandre B, Seron A, Stough WG, Sherman W, Cotter G, Wijns W, CHART Program. Cardiopoietic cell therapy for advanced ischaemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial. Eur Heart J. 2017 Mar 1; 38 (9):648-660
    View PubMed
98. Wang X, Yamada S, LaRiviere WB, Ye H, Bakeberg JL, Irazabal MV, Chebib FT, van Deursen J, Harris PC, Sussman CR, Behfar A, Ward CJ, Torres VE. Generation and phenotypic characterization of Pde1a mutant mice. PLoS One. 2017; 12 (7):e0181087 Epub 2017 July 27
    View PubMed
99. El Sabbagh A, Al-Hijji M, Gulati R, Rihal CS, Pollak PM, Behfar A. Percutaneous Stenting of a Left Ventricular Assist Device Outflow Kink. JACC Cardiovasc Interv. 2016 Dec 26; 9 (24):e229-e231 Epub 2016 Nov 23
    View PubMed
100. Goel K, Gulati R, Reeder GS, Lennon RJ, Lewis BR, Behfar A, Sandhu GS, Rihal CS, Singh M. Low Body Mass Index, Serum Creatinine, and Cause of Death in Patients Undergoing Percutaneous Coronary Intervention. J Am Heart Assoc. 2016 Oct 31; 5 (11)
     View PubMed
101. Terzic A, Behfar A. Stem cell therapy for heart failure: Ensuring regenerative proficiency. Trends Cardiovasc Med. 2016 Jul; 26 (5):395-404 Epub 2016 Jan 28
     View PubMed
102. San-Marina S, Voss S, Crespo-Diaz R, Wyles C, Behfar A, Stalboeger P, Janus JR. Adipose-Derived Mesenchymal Stem Cell Features in Patients with a History of Head and Neck Radiation. Laryngoscope Investig Otolaryngol. 2016 Jun; 1 (3):36-41 Epub 2016 June 10
     View PubMed
103. Houdek MT, Wyles CC, Stalboerger PG, Terzic A, Behfar A, Moran SL. Collagen and Fractionated Platelet-Rich Plasma Scaffold for Dermal Regeneration. Plast Reconstr Surg. 2016 May; 137 (5):1498-1506
     View PubMed
104. Houdek MT, Wyles CC, Packard BD, Terzic A, Behfar A, Sierra RJ. Decreased Osteogenic Activity of Mesenchymal Stem Cells in Patients With Corticosteroid-Induced Osteonecrosis of the Femoral Head. J Arthroplasty. 2016 Apr; 31 (4):893-8 Epub 2015 Aug 29
     View PubMed
105. Faustino RS, Behfar A, Groenendyk J, Wyles SP, Niederlander N, Reyes S, Puceat M, Michalak M, Terzic A, Perez-Terzic C. Calreticulin secures calcium-dependent nuclear pore competency required for cardiogenesis. J Mol Cell Cardiol. 2016 Mar; 92:63-74 Epub 2016 Jan 27
     View PubMed
106. Bartunek J, Davison B, Sherman W, Povsic T, Henry TD, Gersh B, Metra M, Filippatos G, Hajjar R, Behfar A, Homsy C, Cotter G, Wijns W, Tendera M, Terzic A. Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) trial design. Eur J Heart Fail. 2016 Feb; 18 (2):160-8 Epub 2015 Dec 14
     View PubMed
107. Singh M, Jensen MD, Lerman A, Kushwaha S, Rihal CS, Gersh BJ, Behfar A, Tchkonia T, Thomas RJ, Lennon RJ, Keenan LR, Moore AG, Kirkland JL. Effect of Low-Dose Rapamycin on Senescence Markers and Physical Functioning in Older Adults with Coronary Artery Disease: Results of a Pilot Study. J Frailty Aging. 2016; 5 (4):204-207
     View PubMed
108. Johnson TD, Hill RC, Dzieciatkowska M, Nigam V, Behfar A, Christman KL, Hansen KC. Quantification of decellularized human myocardial matrix: A comparison of six patients. Proteomics Clin Appl. 2016 Jan; 10 (1):75-83 Epub 2015 Sept 28
     View PubMed
109. Wyles CC, Houdek MT, Crespo-Diaz RJ, Norambuena GA, Stalboerger PG, Terzic A, Behfar A, Sierra RJ. Adipose-derived Mesenchymal Stem Cells Are Phenotypically Superior for Regeneration in the Setting of Osteonecrosis of the Femoral Head. Clin Orthop Relat Res. 2015 Oct; 473 (10):3080-90 Epub 2015 June 13
     View PubMed
110. Bartunek J, Vanderheyden M, Behfar A. Integrate and boost: bioscaffolds nurture the cardiac regenerative paradigm. Stem Cell Res Ther. 2015 Sep 23; 6:183 Epub 2015 Sept 23
     View PubMed
111. Banovic M, Loncar Z, Behfar A, Vanderheyden M, Beleslin B, Zeiher A, Metra M, Terzic A, Bartunek J. Endpoints in stem cell trials in ischemic heart failure. Stem Cell Res Ther. 2015 Aug 29; 6 (1):159
     View PubMed
112. Dalen M, Behfar A, Terzic A, Schiller P, Seron A, Sherman W, Mansson-Broberg A, Grinnemo KH. Percutaneous fluoroscopic-guided endomyocardial delivery in an experimental model of left ventricular assist device support. Journal Of Cardiovascular Translational Research. 2015 Aug; 8(6):381-4.
     View PubMed
113. Moulay G, Ohtani T, Ogut O, Guenzel A, Behfar A, Zakeri R, Haines P, Storlie J, Bowen L, Pham L, Kaye D, Sandhu G, O'Connor M, Russell S, Redfield M. Cardiac AAV9 Gene Delivery Strategies in Adult Canines: Assessment by Long-term Serial SPECT Imaging of Sodium Iodide Symporter Expression. Mol Ther. 2015 Jul; 23 (7):1211-1221 Epub 2015 Apr 27
     View PubMed
114. Yamada S, Arrell DK, Martinez-Fernandez A, Behfar A, Kane GC, Perez-Terzic CM, Crespo-Diaz RJ, McDonald RJ, Wyles SP, Zlatkovic-Lindor J, Nelson TJ, Terzic A. Regenerative Therapy Prevents Heart Failure Progression in Dyssynchronous Nonischemic Narrow QRS Cardiomyopathy. J Am Heart Assoc. 2015 May 11; 4 (5)
     View PubMed
115. Wyles CC, Houdek MT, Wyles SP, Wagner ER, Behfar A, Sierra RJ. Differential cytotoxicity of corticosteroids on human mesenchymal stem cells. Clin Orthop Relat Res. 2015 Mar; 473 (3):1155-64 Epub 2014 Sept 04
     View PubMed
116. Wyles CC, Houdek MT, Behfar A, Sierra RJ. Mesenchymal stem cell therapy for osteoarthritis: current perspectives. Stem Cells Cloning. 2015; 8:117-24 Epub 2015 Aug 28
     View PubMed
117. Bansal A, Pandey MK, Demirhan YE, Nesbitt JJ, Crespo-Diaz RJ, Terzic A, Behfar A, DeGrado TR. Novel (89)Zr cell labeling approach for PET-based cell trafficking studies. EJNMMI Res. 2015; 5:19 Epub 2015 Mar 28
     View PubMed
118. Orde SR, Behfar A, Stalboerger PG, Barros-Gomes S, Kane GC, Oh JK. Effect of positive end-expiratory pressure on porcine right ventricle function assessed by speckle tracking echocardiography. BMC Anesthesiol. 2015; 15:49 Epub 2015 Apr 11
     View PubMed
119. Crespo-Diaz R, Yamada S, Bartunek J, Perez-Terzic C, de Waele P, Mauen S, Terzic A, Behfar A. Cardiopoietic index predicts heart repair fitness of patient-derived stem cells. Biomark Med. 2015; 9 (7):639-49 Epub 2015 May 27
     View PubMed
120. Behfar A, Terzic A, Perez-Terzic CM. Regenerative principles enrich cardiac rehabilitation practice. Am J Phys Med Rehabil. 2014 Nov; 93 (11 Suppl 3):S169-75
     View PubMed
121. Behfar A, Crespo-Diaz R, Terzic A, Gersh BJ. Cell therapy for cardiac repair--lessons from clinical trials. Nat Rev Cardiol. 2014 Apr; 11 (4):232-46 Epub 2014 Mar 04
     View PubMed
122. Behfar A, Latere JP, Bartunek J, Homsy C, Daro D, Crespo-Diaz RJ, Stalboerger PG, Steenwinckel V, Seron A, Redfield MM, Terzic A. Optimized delivery system achieves enhanced endomyocardial stem cell retention. Cell Biol Int. 2014 Jan; 38(1):710-8.
     
123. Johnson TD, Dequach JA, Gaetani R, Ungerleider J, Elhag D, Nigam V, Behfar A, Christman KL. Human versus porcine tissue sourcing for an injectable myocardial matrix hydrogel. Biomater Sci. 2014; 2014:60283D
     View PubMed
124. Yamada S, Arrell DK, Kane GC, Nelson TJ, Perez-Terzic CM, Behfar A, Purushothaman S, Prinzen FW, Auricchio A, Terzic A. Mechanical dyssynchrony precedes QRS widening in ATP-sensitive K(+) channel-deficient dilated cardiomyopathy. J Am Heart Assoc. 2013 Dec 5; 2 (6):e000410 Epub 2013 Dec 05
     View PubMed
125. Behfar A, Latere JP, Bartunek J, Homsy C, Daro D, Crespo-Diaz RJ, Stalboerger PG, Steenwinckel V, Seron A, Redfield MM, Terzic A. Optimized delivery system achieves enhanced endomyocardial stem cell retention. Circ Cardiovasc Interv. 2013 Dec; 6 (6):710-8 Epub 2013 Dec 10
     View PubMed
126. Behfar A, Valles AG, Gulati R, Sandhu GS. Persistent angina uncovers unusual communication between the left anterior descending and circumflex arteries. Circulation. 2013 Jun 18; 127: (24)2465-6.
     View PubMed
127. Bartunek J, Behfar A, Dolatabadi D, Vanderheyden M, Ostojic M, Dens J, El Nakadi B, Banovic M, Beleslin B, Vrolix M, Legrand V, Vrints C, Vanoverschelde JL, Crespo-Diaz R, Homsy C, Tendera M, Waldman S, Wijns W, Terzic A. Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics. J Am Coll Cardiol. 2013 Jun 11; 61(23):2329-38. Epub 2013 Apr 10.
     View PubMed
128. Baker DJ, Dawlaty MM, Wijshake T, Jeganathan KB, Malureanu L, van Ree JH, Crespo-Diaz R, Reyes S, Seaburg L, Shapiro V, Behfar A, Terzic A, van de Sluis B, van Deursen JM. Increased expression of BubR1 protects against aneuploidy and cancer and extends healthy lifespan. Nat Cell Biol. 2013 Jan; 15 (1):96-102 Epub 2012 Dec 16
     View PubMed
129. Strege P, Beyder A, Bernard C, Crespo-Diaz R, Behfar A, Terzic A, Ackerman M, Farrugia G. Ranolazine inhibits shear sensitivity of endogenous Na+ current and spontaneous action potentials in HL-1 cells. Channels (Austin). 2012 Nov-Dec; 6 (6):457-62 Epub 2012 Sept 27
     View PubMed
130. Muller O, Delrue L, Hamilos M, Vercauteren S, Ntalianis A, Trana C, Mangiacapra F, Dierickx K, De Bruyne B, Wijns W, Behfar A, Barbato E, Terzic A, Vanderheyden M, Bartunek J. Transcriptional fingerprint of human whole blood at the site of coronary occlusion in acute myocardial infarction. EuroIntervention. 2011 Aug; 7(4):458-66.
     View PubMed
131. Dzeja PP, Chung S, Faustino RS, Behfar A, Terzic A. Developmental enhancement of adenylate kinase-AMPK metabolic signaling axis supports stem cell cardiac differentiation. PLoS One. 2011 Apr 27; 6 (4):e19300
     View PubMed
132. Terzic A, Folmes CD, Martinez-Fernandez A, Behfar A. Regenerative medicine: On the vanguard of health care Mayo Clin Proc.2011;86:600-602.
     
133. Crespo-Diaz R, Behfar A, Butler GW, Padley DJ, Sarr MG, Bartunek J, Dietz AB, Terzic A. Platelet lysate consisting of a natural repair proteome supports human mesenchymal stem cell proliferation and chromosomal stability. Cell Transplant. 2011; 20 (6):797-811 Epub 2010 Nov 19
     View PubMed
134. Behfar A, Crespo-Diaz R, Nelson TJ, Terzic A, Gersh BJ. Stem cells: clinical trials results the end of the beginning or the beginning of the end? Cardiovasc Hematol Disord Drug Targets. 2010 Sep 1; 10 (3):186-201
     View PubMed
135. Behfar A, Yamada S, Crespo-Diaz R, Nesbitt JJ, Rowe LA, Perez-Terzic C, Gaussin V, Homsy C, Bartunek J, Terzic A. Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction. J Am Coll Cardiol. 2010 Aug 24; 56 (9):721-34
     View PubMed
136. Faustino RS, Chiriac A, Niederlander NJ, Nelson TJ, Behfar A, Mishra PK, Macura S, Michalak M, Terzic A, Perez-Terzic C. Decoded calreticulin-deficient embryonic stem cell transcriptome resolves latent cardiophenotype. Stem Cells. 2010 Jul; 28 (7):1281-91
     View PubMed
137. Chiriac A, Nelson TJ, Faustino RS, Behfar A, Terzic A. Cardiogenic induction of pluripotent stem cells streamlined through a conserved SDF-1/VEGF/BMP2 integrated network. PLoS One. 2010 Apr 1; 5 (4):e9943 Epub 2010 Apr 01
     View PubMed
138. Gersh BJ, Simari RD, Behfar A, Terzic CM, Terzic A. Cardiac cell repair therapy: a clinical perspective. Mayo Clin Proc. 2009 Oct; 84 (10):876-92
     View PubMed
139. Yamada S, Nelson TJ, Behfar A, Crespo-Diaz RJ, Fraidenraich D, Terzic A. Stem cell transplant into preimplantation embryo yields myocardial infarction-resistant adult phenotype. Stem Cells. 2009 Jul; 27 (7):1697-705
     View PubMed
140. Nelson TJ, Behfar A, Yamada S, Martinez-Fernandez A, Terzic A. Stem cell platforms for regenerative medicine. Clin Transl Sci. 2009 Jun; 2 (3):222-7
     View PubMed
141. Nelson TJ, Chiriac A, Faustino RS, Crespo-Diaz RJ, Behfar A, Terzic A. Lineage specification of Flk-1+ progenitors is associated with divergent Sox7 expression in cardiopoiesis. Differentiation. 2009 Mar; 77 (3):248-55 Epub 2008 Dec 02
     View PubMed
142. Nelson T, Behfar A, Terzic A. Stem cells: biologics for regeneration. Clin Pharmacol Ther. 2008 Nov; 84(5):620-3. Epub 2008 Aug 13.
     View PubMed
143. Behfar A, Faustino RS, Arrell DK, Dzeja PP, Perez-Terzic C, Terzic A. Guided stem cell cardiopoiesis: discovery and translation. J Mol Cell Cardiol. 2008 Oct; 45 (4):523-9 Epub 2008 Sept 26
     View PubMed
144. Yamada S, Nelson TJ, Crespo-Diaz RJ, Perez-Terzic C, Liu XK, Miki T, Seino S, Behfar A, Terzic A. Embryonic stem cell therapy of heart failure in genetic cardiomyopathy. Stem Cells. 2008 Oct; 26(10):2644-53. Epub 2008 Jul 31.
     View PubMed
145. Nelson TJ, Behfar A, Terzic A. Strategies for therapeutic repair: The "R(3)" regenerative medicine paradigm. Clin Transl Sci. 2008 Sep; 1 (2):168-171
     View PubMed
146. Behfar A, Bartunek J, Vanderheyden M, Wijns W, Terzic A. Mesenchymal stem cells and cardaic repair: Principles and practice J Cardiovasc Trans.2008;1:115-119.
     
147. Nelson TJ, Faustino RS, Chiriac A, Crespo-Diaz R, Behfar A, Terzic A. CXCR4+/FLK-1+ biomarkers select a cardiopoietic lineage from embryonic stem cells. Stem Cells. 2008 Jun; 26(6):1464-73. Epub 2008 Mar 27.
     View PubMed
148. Behfar A, Terzic A. Mesenchymal stem cells: engineering regeneration. Clin Transl Sci. 2008 May; 1 (1):34-5
     View PubMed
149. Arrell DK, Niederlander NJ, Faustino RS, Behfar A, Terzic A. Cardioinductive network guiding stem cell differentiation revealed by proteomic cartography of tumor necrosis factor alpha-primed endodermal secretome. Stem Cells. 2008 Feb; 26(2):387-400. Epub 2007 Nov 08.
     View PubMed
150. Faustino RS, Behfar A, Perez-Terzic C, Terzic A. Genomic chart guiding embryonic stem cell cardiopoiesis. Genome Biol. 2008 Jan 9; 9 (1):R6 Epub 2008 Jan 09
     View PubMed
151. Behfar A, Terzic A. Cardioprotective repair through stem cell-based cardiopoiesis. J Appl Physiol (1985). 2007 Oct; 103(4):1438-40. Epub 2007 Jul 19.
     View PubMed
152. Arrell DK, Niederlander NJ, Perez-Terzic C, Chung S, Behfar A, Terzic A. Pharmacoproteomics: advancing the efficacy and safety of regenerative therapeutics. Clin Pharmacol Ther. 2007 Sep; 82(3):316-9. Epub 2007 Aug 01.
     View PubMed
153. Behfar A, Perez-Terzic C, Faustino RS, Arrell DK, Hodgson DM, Yamada S, Puceat M, Niederlander N, Alekseev AE, Zingman LV, Terzic A. Cardiopoietic programming of embryonic stem cells for tumor-free heart repair. J Exp Med. 2007 Feb 19; 204 (2):405-20 Epub 2007 Feb 05
     View PubMed
154. Behfar A, Perez-Terzic C, Faustino RS, Boorsma B, Arrell DK, Niederlander NJ, Terzic A. Stem cell transformation into cardiac phenotype guided by directed cell transformation involves remodeling of nuclear transport machinery Nature Clinical Practice Cardiovascular Medicine.2007;4:S68-S76.
     
155. Chung S, Dzeja PP, Faustino RS, Perez-Terzic C, Behfar A, Terzic A. Mitochondrial oxidative metabolism is required for the cardiac differentiation of stem cells. Nat Clin Pract Cardiovasc Med. 2007 Feb; 4 Suppl 1 (Suppl 1):S60-7
     View PubMed
156. Yamada S, Kane GC, Behfar A, Liu XK, Dyer RB, Faustino RS, Miki T, Seino S, Terzic A. Protection conferred by myocardial ATP-sensitive K+ channels in pressure overload-induced congestive heart failure revealed in KCNJ11 Kir6.2-null mutant. J Physiol. 2006 Dec 15; 577(Pt 3):1053-65. Epub 2006 Oct 12.
     View PubMed
157. Behfar A, Zeineddine D, Papadimou E, Chebli K, Gineste M, Liu J, Grey C, Thurig S, Wallace VA, Skerjanc IS, Puceat M. Oct-3/4 dose dependently regulates specification of embryonic stem cells toward a cardiac lineage and early heart development Dev Cell.2006;11:535-546.
     
158. Kane GC, Behfar A, Dyer RB, O'Cochlain DF, Liu XK, Hodgson DM, Reyes S, Miki T, Seino S, Terzic A. KCNJ11 gene knockout of the Kir6.2 KATP channel causes maladaptive remodeling and heart failure in hypertension. Hum Mol Genet. 2006 Aug 01; 15(15):2285-97. Epub 2006 Jun 16.
     View PubMed
159. Behfar A, Terzic A. Derivation of a cardiopoietic population from human mesenchymal stem cells yields cardiac progeny. Nat Clin Pract Cardiovasc Med. 2006 Mar; 3 Suppl 1:S78-82
     View PubMed
160. Behfar A, Hodgson DM, Zingman LV, Perez-Terzic C, Yamada S, Kane GC, Alekseev AE, Puceat M, Terzic A. Administration of allogenic stem cells dosed to secure cardiogenesis and sustained infarct repair. Ann N Y Acad Sci. 2005 May; 1049:189-98.
     View PubMed
161. Kane GC, Behfar A, Yamada S, Perez-Terzic C, O'Cochlain F, Reyes S, Dzeja PP, Miki T, Seino S, Terzic A. ATP-sensitive K+ channel knockout compromises the metabolic benefit of exercise training, resulting in cardiac deficits. Diabetes. 2004 Dec; 53 Suppl 3:S169-75
     View PubMed
162. O'Cochlain DF, Perez-Terzic C, Reyes S, Kane GC, Behfar A, Hodgson DM, Strommen JA, Liu XK, van den Broek W, Wansink DG, Wieringa B, Terzic A. Transgenic overexpression of human DMPK accumulates into hypertrophic cardiomyopathy, myotonic myopathy and hypotension traits of myotonic dystrophy. Hum Mol Genet. 2004 Oct 15; 13(20):2505-18. Epub 2004 Aug 18.
     View PubMed
163. Hodgson DM, Behfar A, Zingman LV, Kane GC, Perez-Terzic C, Alekseev AE, Puceat M, Terzic A. Stable benefit of embryonic stem cell therapy in myocardial infarction. Am J Physiol Heart Circ Physiol. 2004 Aug; 287 (2):H471-9
     View PubMed
164. Behfar A, Perez-Terzic C, Mery A, van Deursen JM, Terzic A, Puceat M. Commitment of embryonic stem cells toward a cardiac lineage: Molecular mechanisms and evidence for a promising therapeutic approach for heart failure Circ Res.2003;93:444-452.
     
165. Mery A, Papadimou E, Zeineddine D, Menard C, Behfar A, Zingman LV, Hodgson DM, Rauzier JM, Kane GC, Perez-Terzic C, Terzic A, Puceat M. Commitment of embryonic stem cells toward a cardiac lineage: molecular mechanisms and evidence for a promising therapeutic approach for heart failure. J Muscle Res Cell Motil. 2003; 24(4-6):269-74.
     View PubMed
166. Behfar A, Zingman LV, Hodgson DM, Rauzier JM, Kane GC, Terzic A, Puceat M. Stem cell differentiation requires a paracrine pathway in the heart. FASEB J. 2002 Oct; 16(12):1558-66.
     View PubMed